**Core Concept:** Fibronectin is a glycoprotein found in the extracellular matrix of tissues and is released into the cervicovaginal secretions during labor. The presence of fibronectin in the discharge indicates an increased risk of preterm labor.

**Why the Correct Answer is Right:** In the scenario described, a 32 weeks pregnant woman is experiencing intermittent abdominal pain and vaginal discharge with the presence of fibronectin. The release of fibronectin into the cervicovaginal secretions is a sign of the cervical preparation for labor, particularly when combined with other signs such as abdominal pain. Fibronectin detection in the discharge increases the probability of preterm labor, as it is released during the process of cervical ripening and softening (luteal phase cervical changes) that occurs prior to labor.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because fibronectin does not exist in cervicovaginal secretions during normal pregnancy.

B. Although abdominal pain may be present during pregnancy, fibronectin detection is more specific in predicting preterm labor.

C. This option is incorrect as fibronectin detection is more indicative of preterm labor than cervical ripening and softening.

D. This option is incorrect because fibronectin is a significant indicator of preterm labor risk, regardless of the duration of pregnancy.

**Clinical Pearl:** Fibronectin testing is a useful tool in identifying women at risk for preterm labor. In combination with other clinical signs and symptoms, it can help healthcare providers make informed decisions regarding interventions to prevent preterm birth and improve perinatal outcomes.